Clinical Trial Update: Efficacy and Safety of Goat Lung Surfactant for the Treatment of Respiratory Distress Syndrome in Preterm Neonates [Phase 2, Phase 3]

View source ↗

Summary

The document describes a clinical trial update on the efficacy and safety of goat lung surfactant for treating respiratory distress syndrome in preterm neonates…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Goat Lung Surfactant (Goat lung surfactant)

Snippet

Sponsor: Ramesh K Agarwal | Conditions: Respiratory Distress Syndrome | Phase 2, Phase 3 | Status: UNKNOWN